Sign Up Today and Learn More About Clarapath Stock
Invest in or calculate the value of your shares in Clarapath or other pre-IPO companies through EquityZen's platform.

Clarapath Stock (CLAR)
Clarapath is a medical robotics company that develops the SectionStar, a platform to mimic the human histotechnician.
About Clarapath Stock
Founded
2014
Headquarters
New York, NY, US
Industries
Science and Engineering, Health Care, Biotechnology
Clarapath Press Mentions
Stay in the know about the latest news on Clarapath
Pathology Laboratories Market Size to Reach USD 720.60 Billion by 2032, Driven by AI Integration and Rising Chronic Disease Burden – SNS Insider
globenewswire • Apr 14, 2025
Automated tissue section transfer system with high throughput
patents • Feb 08, 2025
Automated Tissue Sectioning and Storage System
patents • Feb 08, 2025
Preliminary Diagnoses of Cut Tissue Sections
patents • Feb 08, 2025
Facing and Quality Control in Microtomy
patents • Feb 08, 2025
Clarapath Management
Leadership team at Clarapath
Board Observer
David Eigen
Director of Finance and Human Resources
Kavita Sethi

Join now and verify your accreditation status to gain access to:
- Clarapath Current Valuation
- Clarapath Stock Price
- Clarapath Management
- Available deals in Clarapath and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Clarapath Cap Table and Funding History by Share Class and Liquidity Preferences
- Clarapath Revenue and Financials
- Clarapath Highlights
- Clarapath Business Model
- Clarapath Risk Factors
- Clarapath Research Report from SACRA Research
Trading Clarapath Stock
How to invest in Clarapath stock?
Accredited investors can buy pre-IPO stock in companies like Clarapath through EquityZen funds. These investments are made available by existing Clarapath shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Clarapath stock?
Shareholders can sell their Clarapath stock through EquityZen's private company marketplace. EquityZen's network includes over 360K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 46K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."